Paper - WANFANG MED ONLINE

You Position: Home > Paper

Progress on serum levels of keratin-18 fragments in chronic hepatitis B and perspective of its application

( views:192, downloads:68 )

Author:: No author available

Journal Title:: Chinese Journal of Clinical Infectious Diseases

Issue:: 4

DOI:: 10.3760/cma.j.issn.1674-2397.2014.04.020

Key Word:: 肝炎,乙型,慢性;凋亡;坏死;角蛋白18;Hepatitis B,chronic;Apoptosis;Necrosis;Keratin-18

Abstract： The diagnostic value of keratin-18 and its fragments in liver diseases has drawn increasingly interests in recent years,but studies on its application in chronic hepatitis B is still few.This paper reviews the circulating levels of keratin-18 fragments M30 and M65 in chronic hepatitis B and its application in the future.

Reference

[1]朱冰,游绍莉,万志红,等.HBV相关慢加急性肝衰竭患者血清M30、M65检测及其临床意义[J].2013,(9).
[2]Omary MB,Ku NO,Strnad P.Toward unraveling the complexity of simple epithelial keratins in human disease.[J].2009,119(7).
[3]C, Caulín,G S, Salvesen,R G, Oshima.Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis.[J].1997,138.
[4]Jany Vassy,Theano Irinopoulou,Michael Beil and,etc.Spatial distribution of cytoskeleton intermediate filaments during fetal rat hepatocyte differentiation[J].1997,39(5).
[5]Heike, Bantel,Andreas, Lügering,Jan, Heidemann,etc.Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury.[J].2004,40.
[6]Weber K,Hesse M,Magin TM.Genes for intermediate filament proteins and the draft sequence of the human genome: novel keratin genes and a surprisingly high number of pseudogenes related to keratin genes 8 and 18.[J].2001,114(Pt.14).
[7]Su-Jun Zheng,Shuang Liu,Mei Liu,etc.Prognostic value of M30/M65 for outcome of hepatitis B virus-related acute-on-chronic liver failure[J].2014,(9).
[8]Lopez AR,Feldstein AE,Wieckowska A.Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study.[J].2009,50(4).
[9]Wisse Eddie,Luo Dianzhong,Vermijlen David,etc.On the Function of Pit Cells, the Liver-Specific Natural Killer Cells[J].1997.
[10]Giannousis IP,Manolakopoulos SG,Hadziyannis E,etc.Changes of serum levels of keratin-18 fragments in hepatitis B e antigen-negative chronic hepatitis B patients under oral antiviral therapy.[J].2011,16(4).
[11]Rutherford,A.,Lin,W.,Lee,W.M.,etc.Development of an accurate index for predicting outcomes of patients with acute liver failure[J].2012,143(5).
[12]R, Moll,W W, Franke,D L, Schiller,etc.The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells.[J].1982,31(1).
[13]Feldstein, Ariel E.,Eguchi, Akiko,Wree, Alexander.Biomarkers of liver cell death[J].2014,60(5).
[14]George V, Papatheodoridis,Emilia, Hadziyannis,Emmanuel, Tsochatzis,etc.Serum apoptotic caspase activity in chronic hepatitis C and nonalcoholic Fatty liver disease.[J].2010,44.
[15]Paschke,S.,Jang,K.-H.,Strnad,P.,etc.Keratins: Markers and modulators of liver disease[J].2012,28(3).
[16]Arturo, Gonzalez-Quintela,Ihab, Abdulkader,Esteban, Otero,etc.Relationship between serum concentrations of keratin-18 and apoptosis in chronic hepatitis C.[J].2010,48.
[17]Herrmann R,Ulukaya E,Linder S,etc.Utilization of cytokeratin-based biomarkers for pharmacodynamic studies.[J].2010,10(3).
[18]Peter Van Eyken,Valeer J. Desmet.Cytokeratins and the liver[J].1993,13(3).
[19]Manns,M.P.,Moeller,S.,Vaske,B.,etc.Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis[J].2012,55(2).
[20]Valva P,Galoppo MC,De Matteo E,etc.Apoptosis markers related to pathogenesis of pediatric chronic hepatitis C virus infection: M30 mirrors the severity of steatosis.[J].2010,82(6).
[21]Kronenberger B,Zeuzem S,Sarrazin C,etc.Dynamics of apoptotic activity during antiviral treatment of patients with chronic hepatitis C.[J].2007,12(5).
[22]Bae,C.B.,Kim,S.S.,Ahn,S.J.,etc.Caspase-cleaved fragments of cytokeratin-18 as a marker of inflammatory activity in chronic hepatitis B virus infection[J].2013,58(4).
[23]Feldstein,A.E.,Alkhouri,N.,DeVito,R.,etc.Serum cytokeratin-18 fragment levels are useful biomarkers for nonalcoholic steatohepatitis in children[J].2013,108(9).
[24]Valva, Pamela,Casciato, Paola,Lezama, Carol,etc.Serum Apoptosis Markers Related to Liver Damage in Chronic Hepatitis C: sFas as a Marker of Advanced Fibrosis in Children and Adults While M30 of Severe Steatosis Only in Children.[J].2013,8(1).
[25]Yonal O,Ozdogan O,Eren F,etc.Caspase-cleaved fragments of cytokeratin 18 in patients with chronic hepatitis B.[J].2010,411(23).
[26]Schutte, B.,Henfling, M.,Kolgen, W.,etc.Keratin 8/18 breakdown and reorganization during apoptosis[J].2004,297(1).
[27]L, Libbrecht,V, Desmet,B, Van Damme,etc.The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells.[J].2000,33(1).
[28]Nam-On, Ku,Roy M, Soetikno,M Bishr, Omary.Keratin mutation in transgenic mice predisposes to Fas but not TNF-induced apoptosis and massive liver injury.[J].2003,37.
[29]Kronenberger,B.,Farnik,H.,Trojan,J.,etc.Nucleos(t)ide analogue treatment reduces apoptotic activity in patients with chronic hepatitis B[J].2011,52(3).
[30]G VPapatheodoridis,EHadziyannis,ETsochatzis,etc.Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection[J].2008,57(4).
[31]Dolar E,Gurel S,Ulukaya E,etc.Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C.[J].2009,15(4).
[32]E, Fuchs,D W, Cleveland.A structural scaffolding of intermediate filaments in health and disease.[J].1998,279.
[33]Lichtinghagen, R.,Pietsch, D.,Bantel, H.,etc.Erratum to: a€œThe Enhanced Liver Fibrosis (ELF) score: Normal values, influence factors and proposed cut-off valuesa€� [J Hepatol 2013; 59:236a€“242][J].2013,59(6).